Cargando…
Molecular Imaging of Oxygenation Changes during Immunotherapy in Combination with Paclitaxel in Triple Negative Breast Cancer
Hypoxia is a common feature of the tumor microenvironment, including that of triple-negative breast cancer (TNBC), an aggressive breast cancer subtype with a high five-year mortality rate. Using [(18)F]-fluoromisonidazole (FMISO) positron emission tomography (PET) imaging, we aimed to monitor change...
Autores principales: | Napier, Tiara S., Lynch, Shannon E., Lu, Yun, Song, Patrick N., Burns, Andrew C., Sorace, Anna G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856084/ https://www.ncbi.nlm.nih.gov/pubmed/36672633 http://dx.doi.org/10.3390/biomedicines11010125 |
Ejemplares similares
-
92418 Molecular imaging of the tumor microenvironment to predict response to combination treatment with immunotherapy in triple negative breast cancer
por: Napier, Tiara S., et al.
Publicado: (2021) -
Preclinical PET Imaging of Granzyme B Shows Promotion of Immunological Response Following Combination Paclitaxel and Immune Checkpoint Inhibition in Triple Negative Breast Cancer
por: Napier, Tiara S., et al.
Publicado: (2022) -
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer
por: Alečković, Maša, et al.
Publicado: (2023) -
Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023) -
Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
por: Huang, Liang, et al.
Publicado: (2017)